$AZN
Market Cap:
$AZN SEC Filings
| Filing | Filed On |
|---|---|
| NOTICE OF RESULTS | 05 Feb 2014 |
| TOTAL VOTING RIGHTS | 03 Feb 2014 |
| AZ COMPLETES BMS DIABETES ACQUISITION | 03 Feb 2014 |
| HOLDING(S) IN COMPANY | 27 Jan 2014 |
| XIGDUO APPROVED IN EU FOR TYPE 2 DIABETES | 22 Jan 2014 |
| BLOCK LISTING APPLICATION | 17 Jan 2014 |
| ASTRAZENECA PROVIDES STRATEGY UPDATE AT JP MORGAN | 14 Jan 2014 |
| US FDA APPROVES FARXIGA? (DAPAGLIFLOZIN) | 13 Jan 2014 |
| US FDA APPROVAL OF FARXIGA (DAPAGLIFLOZIN) | 09 Jan 2014 |
| TOTAL VOTING RIGHTS | 02 Jan 2014 |
| AZ AND SHIONOGI EXTEND CRESTOR AGREEMENT | 27 Dec 2013 |
| AZ TO ACQUIRE BMS SHARE OF DIABETES ASSETS | 19 Dec 2013 |
| DIRECTOR/PDMR SHAREHOLDING | 19 Dec 2013 |
| STATEMENT ON ESOMEPRAZOLE STRONTIUM LAUNCH IN US | 17 Dec 2013 |
| FDA ADVISORY COMMITTEE RECOMMENDS DAPAGLIFLOZIN | 13 Dec 2013 |
| TOP LINE RESULTS FROM PHASE III STUDY OF LESINURAD | 13 Dec 2013 |
| FDA ADVISORY COMMITTEE VOTES ON METRELEPTIN | 12 Dec 2013 |
| EUROPEAN COMMISSION APPROVES FLUENZ TETRA | 06 Dec 2013 |
| BLOCKLISTING INTERIM REVIEW | 02 Dec 2013 |
| TOTAL VOTING RIGHTS | 02 Dec 2013 |
